Drug Profile
ASF 1081
Alternative Names: ASF-1081Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Astion Pharma A/S
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atopic dermatitis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Atopic-dermatitis in Denmark (PO)
- 27 Mar 2006 Clinical trials in Atopic dermatitis in Denmark (PO)